Status:
COMPLETED
Prevalence of Primary Aldosteronism in Patients With Stroke
Lead Sponsor:
Changi General Hospital
Conditions:
Primary Aldosteronism
Stroke
Eligibility:
All Genders
21-80 years
Brief Summary
Strokes leads to significant morbidity and mortality, and hypertension is the most important risk factor for strokes. It is estimated that up to 10% of patients with hypertension have the underlying, ...
Eligibility Criteria
Inclusion
- Age 21-80 years
- Admitted with acute cerebrovascular accident (CVA) or transient ischemic attack (TIA) to the ASU, CGH
- Patients with both ischemic and hemorrhagic strokes
Exclusion
- a. Pregnant patients
Key Trial Info
Start Date :
May 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03789357
Start Date
May 1 2018
End Date
September 30 2021
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changi General Hospital
Singapore, Singapore, 529889